SCANPHARM A/S — Credit Rating and Financial Key Figures

SCANPHARM A/S (CVR number: 16279099) is a company from RUDERSDAL. The company recorded a gross profit of 26.9 mDKK in 2024. The operating profit was 1679.5 kDKK, while net earnings were 582.7 kDKK. The profitability of the company measured by Return on Assets (ROA) was 5 %, which can be considered decent but Return on Equity (ROE) was 32.5 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 6.8 %, a level that can be considered to be very low. This means the company is highly leveraged, with most assets financed through debt. This high level of financial risk could pose challenges in periods of financial distress or rising interest rates. SCANPHARM A/S's liquidity measured by quick ratio was 0.5 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.